RSNA 2010 

Abstract Archives of the RSNA, 2010


LL-CHS-WE3A

CT Fluoroscopy-guided Lung Biopsy versus Conventional CT-guided Lung Biopsy: Prospective Controlled Study for the Assessment of Radiation Dose and Diagnostic Performance

Scientific Informal (Poster) Presentations

Presented on December 1, 2010
Presented as part of LL-CHS-WE: Chest

Participants

Ga Ram Kim MD, Presenter: Nothing to Disclose
Jin Hur MD, Abstract Co-Author: Nothing to Disclose
Sang Min Lee MD, Abstract Co-Author: Nothing to Disclose
Hye-Jeong Lee MD, Abstract Co-Author: Nothing to Disclose
Yoo Jin Hong, Abstract Co-Author: Nothing to Disclose
Ji Eun Nam MD, Abstract Co-Author: Nothing to Disclose
Byoung Wook Choi MD, Abstract Co-Author: Nothing to Disclose
Tae Hoon Kim MD, Abstract Co-Author: Nothing to Disclose
Kyu Ok Choe MD, Abstract Co-Author: Nothing to Disclose

PURPOSE

To prospectively evaluate the radiation dose, procedure time, complication rate, and diagnostic accuracy for CT-guided percutaneous needle aspiration biopsy (NAB) procedures of pulmonary lesions performed with or without fluoroscopic guidance.

METHOD AND MATERIALS

A total of 142 patients were prospectively enrolled to perform CT-guided NAB with (Group I, n = 72) or without (Group II, n = 70) fluoroscopic guidance. The inclusion criteria were lesion size more than 8 mm, but less than 5 cm and lesions of solid nature (ground glass opacity component of less than 50%). Outcome measurements were radiation dose to patients and doctors, total procedure time, and complication rate. Sensitivity, specificity and accuracy was calculated on the basis of 142 NAB results, and compared between the two groups using the chi-square test.

RESULTS

Mean estimated effective patient radiation dose was 6.53 mSv in group I and 2.72 mSv for group II, respectively (p < 0.001). Mean estimated effective doctor dose measured using TLD for whole body and hand were 0.054 mSv and 0.759 mSv in group I and 0.029 mSv and 0.034 mSv in group II, respectively (p < 0.001). The total procedure time was also significantly different between the two groups (17.16 versus 23.53 min, p < 0.001). The complication rate was significantly different between the two groups (13.4% versus 31.4%, p = 0.012). Sensitivity, specificity and accuracy for diagnosing pulmonary lesions were 88.0%, 100% and 91.7% in group I and 87.2%, 100% and 91.4% in group II, respectively (p > 0.05).

CONCLUSION

CT fluoroscopy-guided NAB of pulmonary lesions provides high diagnostic accuracy, comparable to that of conventional CT-guided NAB, and can be performed safely with a significantly shorter procedure time and a significantly lower rate of complications. However, radiation exposure to the patient and doctor was significantly higher than that of conventional CT-guided NAB.

CLINICAL RELEVANCE/APPLICATION

CT fluoroscopy-guided NAB of pulmonary lesions provides high diagnostic accuracy, and is safer than conventional CT-guided NAB, although radiation exposure is higher with CT fluoroscopy-guided NAB.

Cite This Abstract

Kim, G, Hur, J, Lee, S, Lee, H, Hong, Y, Nam, J, Choi, B, Kim, T, Choe, K, CT Fluoroscopy-guided Lung Biopsy versus Conventional CT-guided Lung Biopsy: Prospective Controlled Study for the Assessment of Radiation Dose and Diagnostic Performance.  Radiological Society of North America 2010 Scientific Assembly and Annual Meeting, November 28 - December 3, 2010 ,Chicago IL. http://archive.rsna.org/2010/9004097.html